X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-08-12 | TCMD | Ferstler Sherri Lee | SVP, Sales | S - Sale | $13.07 | -1,550 | 38,764 | -4% | -$20,263 | ||||||
2024-05-16 | TCMD | Birkemeyer Elaine M. | CFO | S - Sale | $13.68 | -3,041 | 61,295 | -5% | -$41,590 | ||||||
2024-05-08 | TCMD | Burke William W | Dir | S - Sale | $14.06 | -2,500 | 35,742 | -7% | -$35,150 | ||||||
2024-05-06 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $14.37 | -815 | 62,574 | -1% | -$11,713 | ||||||
| M | 2024-02-27 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $15.52 | -1,334 | 63,389 | -2% | -$20,707 | |||||
| M | 2024-02-27 | TCMD | Reuvers Daniel L. | Pres, CEO | S - Sale | $15.52 | -6,085 | 238,027 | -2% | -$94,437 | |||||
| M | 2024-02-23 | TCMD | Reuvers Daniel L. | Pres, CEO | S - Sale | $15.37 | -11,617 | 244,112 | -5% | -$178,497 | |||||
| M | 2024-02-23 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $15.32 | -4,264 | 63,512 | -6% | -$65,327 | |||||
2023-08-07 | TCMD | Reuvers Daniel L. | Pres, CEO | S - Sale | $20.53 | -1,062 | 125,653 | -1% | -$21,808 | ||||||
2023-05-12 | TCMD | Burke William W | Dir | S - Sale | $21.86 | -4,400 | 27,773 | -14% | -$96,184 | ||||||
2023-05-08 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $18.65 | -786 | 36,562 | -2% | -$14,659 | ||||||
2023-05-08 | TCMD | Pauls Eric | SVP, Sales | S - Sale | $18.55 | -550 | 29,498 | -2% | -$10,200 | ||||||
2023-03-01 | TCMD | Moen Brent | CFO | S - Sale | $14.10 | -1,391 | 48,760 | -3% | -$19,613 | ||||||
| M | 2023-02-27 | TCMD | Reuvers Daniel L. | Pres, CEO | S - Sale | $15.20 | -7,087 | 126,715 | -5% | -$107,722 | |||||
| M | 2023-02-27 | TCMD | Moen Brent | CFO | S - Sale | $15.32 | -4,052 | 50,151 | -7% | -$62,059 | |||||
| M | 2023-02-27 | TCMD | Burns Kristie | SVP Mktg, Clinical Affairs | S - Sale | $15.34 | -2,297 | 37,348 | -6% | -$35,244 | |||||
| M | 2023-02-27 | TCMD | Pauls Eric | SVP, Sales | S - Sale | $15.29 | -1,473 | 30,048 | -5% | -$22,524 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |